Bottom line
Is HNSGX a good fund? The bottom line
HNSGX is the Retirement Class share class of Harbor Small Cap Growth Fund, a managed small-cap mutual fund from Oakmark (Harris).
It charges 0.8% — about $80 a year on every $10,000 invested, cheaper than 75% of small-cap funds we track.
It returned +11.5% over one year, +4.1% a year over five years, +11.1% a year over ten (as of Dec 31, 2025, per its prospectus).
With $2.7 billion in net assets and 87 holdings, its largest position is Ascendis Pharma A/S (4.1%) and the top 10 make up 22.6% of the portfolio.
What stands out
- Low cost: cheaper than 75% of small-cap peers
What to watch
- 5-year return in the bottom quarter of its category
- High turnover (106% a year) can mean more taxable distributions
Updated Nov 19, 2026
What HNSGX invests in
The Fund seeks long-term growth of capital.
The Fund invests primarily in equity securities, principally common and preferred stocks of small cap companies. Under normal market conditions, the Fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of small cap companies. The Fund defines small cap companies as those with market capitalizations that fall within the range of the Russell 2000 Growth Index, provided that if the upper end of the capitalization range of that Index falls below $2.5 billion, the Fund will continue to define those companies with market capitalizations between the upper end of the range of the Index and $2.5 billion as small cap companies. As of December 31, 2025, the range of the Index was $12 million to $25.69 billion, but it is expected to change frequently. The Subadvisor uses a bottom-up process to identify companies that meet the Subadvisors strict…
From the fund's prospectus (filed Feb 26, 2026).
HNSGX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| HNSGX | +11.5% | +4.1% | +11.1% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What HNSGX costs
On a $10,000 investment, HNSGX's 0.8% expense ratio costs about $80 a year. The prospectus estimates $990 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
HNSGX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Ascendis Pharma A/S | 4.13% |
| 2 | FTAI Aviation Ltd | 3.15% |
| 3 | IMAX Corp | 2.39% |
| 4 | Life Time Group Holdings Inc | 2.33% |
| 5 | Rhythm Pharmaceuticals Inc | 1.91% |
| 6 | ITT Inc | 1.85% |
| 7 | Applied Industrial Technologies Inc | 1.83% |
| 8 | Dynatrace Inc | 1.74% |
| 9 | FirstCash Holdings Inc | 1.73% |
| 10 | Guardant Health Inc | 1.59% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 22.6% of the fund. See all top 25 holdings and asset mix →